PFE241004C20000
- 9.62
- 0.000.00%
Pfizer Newsroom
Sector Update: Health Care Stocks Mixed in Afternoon Trading
Express News | Blocktrade- Haleon PLC Abb (Secondary) - Sale of Shares by Pfizer Inc; Books Are Covered; Further Guidance to Follow - Bookrunner
Pfizer to Offload About 5.9% Stake in UK's Haleon, Says Bookrunner
Pfizer Intends to Sell About 540M Ordinary Shares in Haleon
Pfizer Will Receive All of Net Proceeds From Offering
Pfizer: Price Per Sale Share Will Be Determined by Way of Accelerated Bookbuilding Process to Institutional Investors
Express News | Pfizer Inc Intends to Sell About 540 Mln Ordinary Shares in Haleon PLC - Bookrunner
Pfizer Intends to Sell Approx 540 Million Ordinary Shares in Haleon
Roche Sees Carmot Obesity Drugs' Potential Peak Sales at $3.6B+: Report
Express News | UK's Mhra: Pfizer Limited Is Recalling All Distributed Batches of Oxbryta 500 Mg Tablets
Pipeline Moves: Pfizer Scores in Phase II Cancer Cachexia Trial
Pfizer Inc. (PFE) Acquires Seagen for $43 Billion, Strengthening Oncology Leadership
Stocks With the Highest Consensus of Expected ROE Growth, Goldman Sachs Says
Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent Set to Advance in Top Drug Sales
Here Is What Jim Cramer Likes Pfizer Inc. (NYSE:PFE)
Here Are the Medicare Part D Drugs Expected to Face 2025 Price Negotiations
Pfizer Options Spot-On: On September 27th, 116.74K Contracts Were Traded, With 2.8 Million Open Interest
Achieve, INmune, Lenz Gain on Bullish Initiations From Raymond James
Pfizer Call Volume Above Normal and Directionally Bullish
Today's Analyst Rating | Meta Platforms Price Target Raised to $605 by Baird, Accenture Price Target Raised to $370 by Goldman Sachs